This proposal provides an integrated solution “NOVELFOOD” (DE-RISKING AND DOSSIER SUBMISSION TO REGULATORY AGENCIES) for cellbased food .

While the work is largely the same for different indications, low dose selection for toxicology studies and saftey dosing should be tailored to the first indication planned to be tested in a laboratory setting. The proposed workpackage, covers all the necessary activities to progress one cellbased product to regulatory submission.

The objective is to enable safe and rapid entry into first time in human volunteer studies, conducted by our consortium partners.

The plan provides a solid foundation for the overall development of cellbased food products, excludes  the exclusion  of invivo animal studies while balancing development cost, risks and timelines.

The plan includes  the use of human or animal Organoid  models in order to understand and simulate  the kinetic and dynamic behavior of all products in their organism.

Image 2.: Organ on a chip prototype


Our first novel food de-risking project is the development and de-risking of a new-cellbased food product called MAGICCAVIAR™️. Whereas we will act as an CRO -contracted research organization and CDMO -contracted development and manufacturing organization for a cellular agriculture biotech spinoff named MAGICCAVIAR.

The project aims to license our patent pending stemcell merger technology in order to produce LAB GROWN BELUGA CAVIAR - from cruelty free harvested biopsies of the highly endangered Huso huso sturgeon.